BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21807097)

  • 1. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study.
    Chong SA; Benilova I; Shaban H; De Strooper B; Devijver H; Moechars D; Eberle W; Bartic C; Van Leuven F; Callewaert G
    Neurobiol Dis; 2011 Dec; 44(3):284-91. PubMed ID: 21807097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.
    Breyhan H; Wirths O; Duan K; Marcello A; Rettig J; Bayer TA
    Acta Neuropathol; 2009 Jun; 117(6):677-85. PubMed ID: 19387667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain.
    Arendash GW; Lewis J; Leighty RE; McGowan E; Cracchiolo JR; Hutton M; Garcia MF
    Brain Res; 2004 Jun; 1012(1-2):29-41. PubMed ID: 15158158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning discloses abnormal structural and functional plasticity at hippocampal synapses in the APP23 mouse model of Alzheimer's disease.
    Middei S; Roberto A; Berretta N; Panico MB; Lista S; Bernardi G; Mercuri NB; Ammassari-Teule M; Nisticò R
    Learn Mem; 2010 May; 17(5):236-40. PubMed ID: 20404004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease.
    Gelman S; Palma J; Tombaugh G; Ghavami A
    J Alzheimers Dis; 2018; 61(1):195-208. PubMed ID: 29154272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
    Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H
    Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of large-conductance Ca(2+)-activated K(+) channels depresses basal synaptic transmission in the hippocampal CA1 area in APP (swe/ind) TgCRND8 mice.
    Ye H; Jalini S; Mylvaganam S; Carlen P
    Neurobiol Aging; 2010 Apr; 31(4):591-604. PubMed ID: 18547679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
    Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I
    FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related synaptic dysfunction in Tg2576 mice starts as a failure in early long-term potentiation which develops into a full abolishment of late long-term potentiation.
    Fernández-Fernández D; Dorner-Ciossek C; Kroker KS; Rosenbrock H
    J Neurosci Res; 2016 Mar; 94(3):266-81. PubMed ID: 26629777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein.
    Fitzjohn SM; Morton RA; Kuenzi F; Rosahl TW; Shearman M; Lewis H; Smith D; Reynolds DS; Davies CH; Collingridge GL; Seabrook GR
    J Neurosci; 2001 Jul; 21(13):4691-8. PubMed ID: 11425896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes.
    Hermann D; Both M; Ebert U; Gross G; Schoemaker H; Draguhn A; Wicke K; Nimmrich V
    Neuroscience; 2009 Sep; 162(4):1081-90. PubMed ID: 19477243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal induction but accelerated decay of LTP in APP + PS1 transgenic mice.
    Gureviciene I; Ikonen S; Gurevicius K; Sarkaki A; van Groen T; Pussinen R; Ylinen A; Tanila H
    Neurobiol Dis; 2004 Mar; 15(2):188-95. PubMed ID: 15006688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the involvement of calbindin D28k in the presenilin 1 model of Alzheimer's disease.
    Odero GL; Oikawa K; Glazner KA; Schapansky J; Grossman D; Thiessen JD; Motnenko A; Ge N; Martin M; Glazner GW; Albensi BC
    Neuroscience; 2010 Aug; 169(1):532-43. PubMed ID: 20399254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse correlation between amyloid precursor protein and synaptic plasticity in transgenic mice.
    Matsuyama S; Teraoka R; Mori H; Tomiyama T
    Neuroreport; 2007 Jul; 18(10):1083-7. PubMed ID: 17558301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.